Search for products, methods, support...
Announcing NextSeq 1000 and NextSeq 2000.
Kits & Reagents
The power of high-throughput sequencing on a benchtop system with the v2.5 flow cell for greater stability and robustness
Selection & Planning Tools
Prepare sequencing libraries for small genomes, PCR amplicons, plasmids, or cDNA in as little as 90 minutes
Software & Informatics Products
Accurate, rapid analysis for germline and somatic exome experiments
Verify instrument installation and operation, obtain an audit-ready report
Find popular product groupings designed for your workflow
Generating RNA libraries from ultra-low-input samples
By Dr Phil Febbo, Chief Medical Officer at Illumina
All Investor Information
Upgrade solution for Illumina systems
All Support Tools
Product Support Services
Cancer Genomics Products
Microbial Genomics Research
Microbial Genomics Products
Complex Disease Research Products
Assay targeting multiple variant types, including tumor mutational burden (TMB) and microsatellite instability (MSI), even from low-quality samples.
Cost-efficient flexibility for new and emerging applications.
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.
A fast, integrated workflow for a wide range of applications, from human whole-genome sequencing to amplicons, plasmids, and microbial species.
Our clinical cancer research solutions deliver accurate genomic information, and enable labs to analyze multiple genes in a single test.
Illumina NGS and array technologies deliver fast, accurate information that can guide choices along the reproductive and genetic health journey.
These assays generate target-enriched cDNA libraries from RNA, even from FFPE samples, for cancer gene fusion studies using Illumina sequencing.
This is the international website for Illumina. If you are looking for information specific to your region, please select your location and we will redirect you.